Cedur Retard (Bezafibrate)

Cedur Retard contains Bezafibrate, a medication used to manage lipid levels and support cardiovascular health. It is designed for oral use and is manufactured by Puren Pharma GmbH & Co. KG.

Cedur Retard is primarily used to help lower lipid levels in the blood, including cholesterol and triglycerides. It is often prescribed as part of a broader strategy to manage cardiovascular health. Bezafibrate works by reducing the production of certain fats in the liver, which can help improve overall lipid profiles.

Common effects of Cedur Retard may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may also experience muscle pain or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Cedur Retard should be handled with care, especially by individuals with pre-existing liver or kidney conditions. It is important to follow the prescribed dosage and administration instructions. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Bezafibrate can interact with certain medications, including blood thinners and other lipid-lowering drugs. It is also advisable to avoid alcohol while taking Cedur Retard, as it may increase the risk of side effects. Always consult a healthcare provider before starting any new medication.